New Webinar:
Overcoming Volume and Viscosity Barriers in Biologic Formulations
NOV 12 | 2025 | 4 PM (CET)
Key Considerations for Container Compatibility and Device Integration in Subcutaneous Drug Delivery
The pharmaceutical and healthcare sector is evolving due to key trends: rising chronic disease rates, a shift toward home-based care, growth in biologics, and a transition from intravenous (IV) to subcutaneous (SC) drug delivery.
These developments present major formulation and delivery challenges.
Biologics like mAbs require higher volumes and concentrations to ensure stability and reduce dosing frequency, often leading to high viscosity.
Our New Plant in Fishers, IN, U.S.
The new U.S. hub in Fishers is designed to support North American pharmaceutical customers.
The facility houses state-of-the-art production lines equipped with advanced process technologies to produce drug containment solutions and drug delivery devices, and an after-sales support center for equipment.
Your Trusted Integrated Solutions Provider
Stevanato Group is a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries. The Group delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle at each of the development, clinical, and commercial stages.
News & Press Releases
Discover all
News & Press Releases
Media Wall
Discover all
Study Concludes the Usability of Nested Vials for Lyo
JUN 30 |
2025
The Constraints and Innovations in the Packaging of Biologic Drugs
MAY 20 |
2025
Optimising primary packaging solutions for mRNA therapies
MAY 20 |
2025
Media Wall
JUN 30 |
2025
Study Concludes the Usability of Nested Vials for Lyo
MAY 20 |
2025
The Constraints and Innovations in the Packaging of Biologic Drugs
MAY 20 |
2025
Optimising primary packaging solutions for mRNA therapies
Upcoming Events & Webinars
